The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study

BMC Complementary and Alternative Medicine

Aslak Steinsbekk²  Odd Georg Nilsen¹  Ane Djuv¹ 

[1]St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

[2]Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway

关键词: Polypharmacy;    Polyherbacy;    Elderly;    Complementary therapy;    Disclosure;    herbal use;    Safety;    General practice;    Herb-drug interaction;   

Others  :  1220837
DOI  :  10.1186/1472-6882-13-295

 received in 2013-04-10, accepted in 2013-10-23,  发布年份 2013

【 摘 要 】

Background

Different patient groups are known to use herbal remedies and conventional drugs concomitantly (co-use). This poses a potential risk of herb-drug interaction through altering the drug’s pharmacokinetics or pharmacodynamics. Little is known about co-use among patients in general practice. The primary aim of this study was to compare patients in general practice that co-use herbal remedies and conventional drugs with those who do not. The secondary aim was to register the herb-drug combinations with potential clinical relevant interactions among the co-users.

Method

A questionnaire based cross-sectional study conducted in the autumn 2011 in a general practice office with four general practitioners (GPs) and one intern in Western Norway. Adults >18 years who came for an office visit were invited. The questionnaire asked about demographics, herbal use, conventional drug use and communication about herbal use. Multivariable logistic regression was used to compare co-users to the other patients.

Results

Of the 381 patients who completed the questionnaire, the prevalence of herbal use was 44%, with bilberry (41%), green tea (31%), garlic (27%), Aloe vera (26%) and echinacea (18%) as the most frequently used. Among those using conventional drugs regularly, 108 (45%) co-used herbs. Close to 40% of patients on anticoagulants co-used herbs, with garlic and bilberry as the most frequent herbs. Compared to all other patients, co-users had significantly (p < 0.05) increased odds to be female (adjOR 2.0), age above 70 years (adjOR 3.3), use herbs to treat an illness (adjOR 4.2), use two or more herbs (polyherbacy, adjOR 12.1) and having experienced adverse effects of herbal use (adjOR 37.5). Co-use was also associated with use of analgesics or dermatological drugs (adjOR 5.1 and 7.9 respectively). Three out of four patients did not discuss herbal use with any health care professional.

Conclusion

A sizable proportion of the GP patients co-used herbs with conventional drugs, also combinations with reported interaction potential or additive effects like anticoagulants and garlic. The low disclosure of herbal use to their GP, polyherbacy and the risk of interactions in vulnerable groups like elderly and chronically ill patients, warrant increased awareness among GPs.

【 授权许可】

   
2013 Djuv et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Messina BA: Herbal supplements: facts and myths–talking to your patients about herbal supplements. J Perianesth Nurs 2006, 21:268-278.
• [2]Waaseth M, Eggen AE, Grimsgaard S: Natural remedies in Scandinavia-authorization and sales. Pharm World Sci 2007, 29:137-145.
• [3]Yang AK, He SM, Liu L, Liu JP, Wei MQ, Zhou SF: Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Cur Med Chem 2010, 17:1635-1678.
• [4]van den Berg SJ, Serra-Majem L, Coppens P, Rietjens IM: Safety assessment of plant food supplements (PFS). Food Func 2011, 2:760-768.
• [5]Mannel M: Drug interactions with St John’s wort : mechanisms and clinical implications. Drug Saf 2004, 27:773-797.
• [6]Izzo AA: Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005, 19:1-16.
• [7]Williamson EM: Interactions between herbal and conventional medicines. Expert Opin Drug Saf 2005, 4:355-378.
• [8]Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W, Woods J: Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 2008, 9:1063-1120.
• [9]Mohammed Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ: Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008, 154:1691-1700.
• [10]Woodward KN: The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 2005, 24:219-233.
• [11]Cohen PA, Ernst E: Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther 2010, 28:246-253.
• [12]Gurley BJ, Fifer EK, Gardner Z: Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance. Planta Med 2012, 78:1490-1514.
• [13]van den Berg SJ, Serra-Majem L, Coppens P, Rietjens IM: Safety assessment of plant food supplements (PFS). Food Funct 2011, 2:760-768.
• [14]Martin KJ, Jordan TR, Vassar AD, White DB: Herbal and nonherbal alternative medicine use in Northwest Ohio. Ann Pharmacother 2002, 36:1862-1869.
• [15]Johansen R, Toverud EL: Norwegian cancer patients and the health food market–what is used and why? Tidsskr Nor Laegeforen 2006, 126:773-775.
• [16]Jean D, Cyr C: Use of complementary and alternative medicine in a general pediatric clinic. Pediatrics 2007, 120:e138-e141.
• [17]Complementary and alternative medicine Use among adults and children: United States, 2007 2012. [ http://www.cdc.gov/nchs/data/nhsr/nhsr012.pdf webcite]
• [18]Giveon SM, Liberman N, Klang S, Kahan E: A survey of primary care physicians’ perceptions of their patients’ use of complementary medicine. Complement Ther Med 2003, 11:254-260.
• [19]Saw JT, Bahari MB, Ang HH, Lim YH: Herbal use amongst multiethnic medical patients in Penang hospital: pattern and perceptions. Med J Malaysia 2006, 61:422-432.
• [20]Smith MB, Christensen N, Wang S, Strohecker J, Day JD, Weiss JP, Crandall BG, Osborn JS, Anderson JL, Horne BD, et al.: Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology 2010, 116:61-69.
• [21]Nordeng H, Bayne K, Havnen GC, Paulsen BS: Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract 2011, 17:147-151.
• [22]Zhang ZJ, Tan QR, Tong Y, Wang XY, Wang HH, Ho LM, Wong HK, Feng YB, Wang D, Ng R, et al.: An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction. PLoS One 2011, 6:e17239.
• [23]Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, et al.: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16:655-663.
• [24]Engdal S, Steinsbekk A, Klepp O, Nilsen OG: Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer 2008, 16:763-769.
• [25]Loya AM, Gonzalez-Stuart A, Rivera JO: Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study. Drugs Aging 2009, 26:423-436.
• [26]Bruno JJ, Ellis JJ: Herbal use among US elderly: 2002 National health interview survey. Ann Pharmacother 2005, 39:643-648.
• [27]Raji MA, Kuo YF, Snih SA, Sharaf BM, Loera JA: Ethnic differences in herb and vitamin/mineral use in the elderly. Ann Pharmacother 2005, 39:1019-1023.
• [28]Asdaq SM, Inamdar MN: Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. Phytother Res 2010, 24:720-725.
• [29]Elolemy AT, Albedah AM: Public knowledge, attitude and practice of complementary and alternative medicine in riyadh region, Saudi Arabia. Oman Med J 2012, 27:20-26.
• [30]Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N: Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Aff 2007, 26:w717-w734.
• [31]Ravven SE, Zimmerman MB, Schultz SK, Wallace RB: 12-Month herbal medicine use for mental health from the national comorbidity survey replication (NCS-R). Ann Clin Psychiatry 2011, 23:83-94.
• [32]Kuo GM, Hawley ST, Weiss LT, Balkrishnan R, Volk RJ: Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med 2004, 4:18. BioMed Central Full Text
• [33]Giveon SM, Liberman N, Klang S, Kahan E: Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician? Patient Educ Couns 2004, 53:5-11.
• [34]The european definitions of general practice/family medicine [ http://www.woncaeurope.org/sites/default/files/documents/Definition%20EURACTshort%20version.pdf webcite], Access date: 30.11
• [35]Prescibed drugs statistics 2011 [ http://www.reseptregisteret.no/Prevalens.aspx webcite], Access date: 01.07
• [36]Market data [ http://brn.no/brn.no/brnno/Bransjen/Markedsdata/ webcite], Access date: 15.09
• [37]Herbal medicinal products [ http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000208.jsp&mid=WC0b01ac05800240cf webcite], Access date: 18.07.12
• [38]Grytten J, Skau I, Sørensen RJ, Aasland OG: Fastlegereformen - En analyse av fastlegenes arbeidsbelastning og tjenestetilbud. Tidsskrift Den Norske Lægeforening 2005, 125:1357-1360.
• [39]Knotek K, Verner V, Chaloupkova P, Kokoska L: Prevalence and use of herbal products in the Czech Republic: over-the-counter survey among adult pharmacies clients. Complement Ther Med 2012, 20:199-206.
• [40]Moussally K, Oraichi D, Berard A: Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf 2009, 18:454-461.
• [41]Bent S, Ko R: Commonly used herbal medicines in the United States: a review. Am J Med 2004, 116:478-485.
• [42]The truth about the health benefits of blueberries [ http://ehealthmd.com/content/truth-about-health-benefits-blueberries webcite], Access date: 18.07.12
• [43]Abebe W: An overview of herbal supplement utilization with particular emphasis on possible interactions with dental drugs and oral manifestations. J Dent Hyg 2003, 77:37-46.
• [44]Yoon SL, Horne CH: Perceived health promotion practice by older women: use of herbal products. J Gerontol Nurs 2004, 30:9-15.
• [45]Shahrokh LE, Lukaszuk JM, Prawitz AD: Elderly herbal supplement users less satisfied with medical care than nonusers. J Am Diet Assoc 2005, 105:1138-1140.
• [46]Cohen RJ, Ek K, Pan CX: Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A Biol Sci Med Sci 2002, 57:M223-M227.
• [47]Canter PH, Ernst E: Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions. Drugs Aging 2004, 21:597-605.
• [48]Kennedy J: Herb and supplement use in the US adult population. Clin Ther 2005, 27:1847-1858.
• [49]Karlsen A, Paur I, Bohn SK, Sakhi AK, Borge GI, Serafini M, Erlund I, Laake P, Tonstad S, Blomhoff R: Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 2010, 49:345-355.
• [50]Aktas CSV, Sarikaya S, Karit S: Bilberry potentiates warfarin effect? Turk J Geriatr 2011, 14:79-81.
• [51]Shord SS, Shah K, Lukose A: Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther 2009, 8:208-227.
• [52]Chan HT, So LT, Li SW, Siu CW, Lau CP, Tse HF: Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. J Cardiovasc Pharmacol 2011, 58:87-90.
• [53]Djuv A, Nilsen OG: Aloe vera juice: IC(5)(0) and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res 2012, 26:445-451.
• [54]Djuv A, Nilsen OG: Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice. Phytother Res 2008, 22:1623-1628.
• [55]Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ: The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. J Clin Pharmacol 2009, 49:824-830.
• [56]Yeung JH, Or PM: Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. Phytomedicine 2012, 19:457-463.
• [57]Abebe W: Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002, 27:391-401.
• [58]Alaaeddine NM, Adib SM, Alawieh HM, Adibilly SM, Khalil MM, Assaad SE, Khayat MC: Use of herbal medications and their perceived effects among adults in the greater beirut area. J Med Liban 2012, 60:45-50.
• [59]Efferth T, Kaina B: Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab 2011, 12:989-996.
• [60]Cvijovic KHB, Joanne B, Jayna B, Walter J, Mano M, Duc V, Susanne R, Sunita V: A tool for rapid identification of potential herbal medicine–drug interactions. Can Pharm J 2009, 142:224-227.
• [61]Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY: Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John’s wort, garlic oil, panax ginseng and ginkgo biloba. Drugs Aging 2005, 22:525-539.
• [62]Carrasco MC, Vallejo JR, Pardo-de-Santayana M, Peral D, Martin MA, Altimiras J: Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res 2009, 23:1795-1796.